DH

David Hainsworth

Algorae Pharmaceuticals Limited | Executive Chairman, Executive Director, Interim CEO
Mr Hainsworth has more than 25 years' experience in capital markets, having spent his career as an investment advisor at Euroz Hartleys Ltd (ASX: EZL), and most recently at Alignment Capital Pty Ltd. Mr Hainsworth's experience spans corporate finance and capital raising, including the origination and execution of capital markets transactions, with emphasis on early-stage ventures in the biotechnology and life sciences industries.

Company and Roles

Company
Title
Tenure
Since
1AI
1AI
Algorae Pharmaceuticals Limited
  • Executive Chairman
  • Executive Director
  • Interim CEO
3yrs, 9mthJan 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
1AI
1AI
Algorae Pharmaceuticals Limited
30/06/2620,000,0005,937,500N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
1AI
1AI
Algorae Pharmaceuticals Limited
05/03/26
Exercise
312,500$0.012$3,750Exercise of options
1AI
1AI
Algorae Pharmaceuticals Limited
05/03/26
Buy
312,500$0.012$3,750Exercise of options
1AI
1AI
Algorae Pharmaceuticals Limited
22/12/25
Issued
5,125,000$0.001$5,125As advised by the company
1AI
1AI
Algorae Pharmaceuticals Limited
03/10/25
Issued
30,000,000$0.010$285,000Issue of securities
1AI
1AI
Algorae Pharmaceuticals Limited
25/10/24
Issued
20,000,000$0.006$120,000Issue of securities